Home > PS Ratio > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
PS (Price/Sales) Ratio

The Current P/S Ratio of OXYGENTA PHARMACEUTICAL is 4.11.

Share Price ₹78.9Apr 01,2025
Market Cap ₹292.0 Cr
Sales-TTM₹71.1 CrTTM-Standalone Results
Price/Sales4.11xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of OXYGENTA PHARMACEUTICAL

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of OXYGENTA PHARMACEUTICAL is calculated as :

Current Market Cap [ ₹292.0 Cr] as on Apr 01,2025

(/) Sales [ ₹71.1 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 4.11x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for OXYGENTA PHARMACEUTICAL , the investors are currently willing to pay '4.11 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of OXYGENTA PHARMACEUTICAL !

The chart below summarizes the trend in P/S Ratio of OXYGENTA PHARMACEUTICAL over the last five years.

Historical PS (Price/Sales) ratio chart of OXYGENTA PHARMACEUTICAL


PS Ratio Performance Analysis for OXYGENTA PHARMACEUTICAL

- OXYGENTA PHARMACEUTICAL 's latest p/e ratio is 4.11x.

- OXYGENTA PHARMACEUTICAL 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.94x.

- OXYGENTA PHARMACEUTICAL 's operated at median p/e ratio of 0.56x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, OXYGENTA PHARMACEUTICAL 's p/e ratio peaked in Mar2024 at 2.45x.

- OXYGENTA PHARMACEUTICAL 's p/e ratio hit its five-year low in Mar2021 of 0x.


How does OXYGENTA PHARMACEUTICAL 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
OXYGENTA PHARMACEUTICAL 71.14.11292.0
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.89407,155.0
DIVIS LABORATORIES LTD9,078.016.23147,295.0
CIPLA LTD26,981.24.32116,664.0
TORRENT PHARMACEUTICALS LTD11,302.09.53107,678.0
DR REDDYS LABORATORIES LTD31,229.33.0896,162.6
MANKIND PHARMA LTD11,641.08.71101,358.0
ZYDUS LIFESCIENCES LTD22,247.43.9788,297.0
LUPIN LTD22,001.64.0689,322.4
AUROBINDO PHARMA LTD30,921.82.1365,912.3
ABBOTT INDIA LTD6,243.210.3164,397.8

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs OXYGENTA PHARMACEUTICAL 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.13x
Max industry PS 16.23x
Median industry PS 4.32x
Average industry PS 6.76x



You may also like the below Video Courses